OTCMKTS:QBIO - Q BioMed Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$1.69 0.00 (0.00 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$1.69
Today's Range$1.62 - $1.69
52-Week Range$0.90 - $3.95
Volume56,302 shs
Average Volume69,442 shs
Market Capitalization$24.42 million
P/E RatioN/A
Dividend YieldN/A
Beta5.22
Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89, a radiopharmaceutical agent for the treatment of pain associated with metastatic bone cancer. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma. Q BioMed Inc. has a partnership with Sphaera Pharma to develop an analog of QBM-001 for pediatric developmental nonverbal disorder; and a collaborative agreement with SRI International to provide formulation development, preclinical development, and early clinical manufacturing of QBM-001. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was founded in 2013 and is based in New York, New York.

Receive QBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for QBIO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:QBIO
Previous SymbolNASDAQ:QBIO
CUSIPN/A
Phone212-588-0022

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.03 per share

Profitability

Net Income$-14,540,000.00

Miscellaneous

Employees2
Market Cap$24.42 million
Next Earnings DateN/A
OptionableNot Optionable

Q BioMed (OTCMKTS:QBIO) Frequently Asked Questions

What is Q BioMed's stock symbol?

Q BioMed trades on the OTCMKTS under the ticker symbol "QBIO."

How were Q BioMed's earnings last quarter?

Q BioMed Inc (OTCMKTS:QBIO) issued its quarterly earnings results on Monday, July, 16th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.24) by $0.10. View Q BioMed's Earnings History.

What price target have analysts set for QBIO?

1 brokers have issued 12 month price objectives for Q BioMed's stock. Their predictions range from $1.85 to $1.85. On average, they expect Q BioMed's stock price to reach $1.85 in the next twelve months. This suggests a possible upside of 9.5% from the stock's current price. View Analyst Price Targets for Q BioMed.

What is the consensus analysts' recommendation for Q BioMed?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Q BioMed in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Q BioMed.

Has Q BioMed been receiving favorable news coverage?

News headlines about QBIO stock have been trending neutral this week, InfoTrie Sentiment reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Q BioMed earned a daily sentiment score of 0.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near future.

Who are some of Q BioMed's key competitors?

What other stocks do shareholders of Q BioMed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Q BioMed investors own include Otonomy (OTIC), New Age Beverages (NBEV), Canopy Growth (CGC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Washington Trust Bancorp (WASH), Micron Technology (MU), Opko Health (OPK), Adobe (ADBE) and VMware (VMW).

Who are Q BioMed's key executives?

Q BioMed's management team includes the folowing people:
  • Mr. Denis D. Corin, Chairman, CEO, Pres & CFO (Age 46)
  • Mr. William S. Rosenstadt, Gen. Counsel & Director (Age 51)
  • Mr. David Laskow-Pooley, VP of Product Devel. (Age 65)
  • Mr. Robert Derham, VP of Orphan Products
  • Mr. Ari Jatwes, Bus. Devel. Analyst

How do I buy shares of Q BioMed?

Shares of QBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Q BioMed's stock price today?

One share of QBIO stock can currently be purchased for approximately $1.69.

How big of a company is Q BioMed?

Q BioMed has a market capitalization of $24.42 million. Q BioMed employs 2 workers across the globe.

What is Q BioMed's official website?

The official website for Q BioMed is http://www.qbiomed.com.

How can I contact Q BioMed?

Q BioMed's mailing address is 366 MADISON AVENUE 3RD FLOOR, NEW YORK NY, 10017. The company can be reached via phone at 212-588-0022.


MarketBeat Community Rating for Q BioMed (OTCMKTS QBIO)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  73 (Vote Outperform)
Underperform Votes:  80 (Vote Underperform)
Total Votes:  153
MarketBeat's community ratings are surveys of what our community members think about Q BioMed and other stocks. Vote "Outperform" if you believe QBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2019 by MarketBeat.com Staff

Featured Article: What is Depreciation?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel